
Harvard research identifies SRSF1 as a regulator of cellular aging. Discover what the findings mean for fibroblasts and regenerative medicine.

Harvard research identifies SRSF1 as a regulator of cellular aging. Discover what the findings mean for fibroblasts and regenerative medicine.

Japan has begun a pioneering stem-cell-based treatment for Parkinson's disease. Discover how it works and what it means for regenerative medicine.

Stem cell research explores cellular rejuvenation, Alzheimer's disease, and the future of regenerative medicine. Discover why cell banking matters.

Stem cell therapy for wrinkles takes a regenerative approach to skin aging. Here is what the science shows and why banking younger cells may matter.

A landmark JAMA trial compared patients’ own stem cells with donor cells, revealing why autologous MSCs matter for regenerative medicine.

Your stem cells age with you. Discover how donor age affects MSC expansion, resilience, and regenerative potential — and why earlier banking matter.

More cells, more potential? Explore what 26 clinical studies reveal about MSC dose, culture expansion, and knee osteoarthritis.

Stem cells age with us. Research shows younger cells divide more, age more slowly, and may offer greater potential for the future.

Dr. Ronna Parsa shares how regenerative medicine, recovery, and stem cells are reshaping orthopedic care and longevity.
RYC Orthopaedics PA Jenna Trainor shares her philosophy on practicing regenerative medicine and orthobiologics for better healthspan and lifespan